| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 58.27▲ | 58.29▲ | 58.24▲ | 57.35▲ | 56.40▲ |
| MA10 | 58.32▲ | 58.21▲ | 58.24▲ | 57.53▲ | 55.17▲ |
| MA20 | 58.31▲ | 58.19▲ | 57.82▲ | 56.78▲ | 53.77▲ |
| MA50 | 58.18▲ | 57.47▲ | 57.16▲ | 55.39▲ | 47.10▲ |
| MA100 | 58.22▲ | 57.19▲ | 57.27▲ | 53.18▲ | 42.48▲ |
| MA200 | 57.91▲ | 57.06▲ | 55.37▲ | 48.30▲ | 31.82▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.035▼ | 0.029▲ | 0.040▲ | 0.075▲ |
| RSI | 53.409▲ | 57.613▲ | 60.654▲ | 59.038▲ | 64.254▲ |
| STOCH | 50.389 | 52.309 | 38.585 | 53.860 | 61.930 |
| WILL %R | -32.051 | -64.453 | -44.000 | -21.616▲ | -13.949▲ |
| CCI | -13.282 | -5.163 | 44.810 | 68.989 | 121.206▲ |
|
Thursday, September 17, 2026 08:02 AM
President and CEO Michael Morrissey said the company is focused on expanding its oncology franchises through internal development, selective business development and potential collaborations, while pr ...
|
|
Thursday, September 17, 2026 05:30 AM
Exelixis, Inc. (NASDAQ:EXEL) disclosed in a September 11 filing that the FDA had extended the review of zanzalintinib by three months, setting a new target action date of March 3, 2027. The September ...
|
|
Tuesday, September 15, 2026 04:04 AM
Exelixis (NASDAQ:EXEL) executives outlined plans to continue expanding the CABOMETYX franchise while preparing for a potential launch of zanzalintinib, or zanza, in colorectal cancer later this year.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/09/26 | 58.285 | 59.15 | 57.895 | 58.36 | 5,242,328 |
| 17/09/26 | 57.23 | 58.52 | 57.23 | 58.49 | 1,687,722 |
| 16/09/26 | 57.04 | 57.78 | 56.325 | 56.78 | 1,879,628 |
| 15/09/26 | 55.93 | 56.97 | 54.945 | 56.90 | 1,973,024 |
| 14/09/26 | 56.44 | 57.07 | 55.91 | 56.21 | 1,670,445 |
| 11/09/26 | 56.76 | 57.43 | 54.545 | 56.12 | 2,883,197 |
| 10/09/26 | 58.33 | 58.33 | 57.23 | 57.43 | 1,789,572 |
| 09/09/26 | 57.60 | 58.36 | 56.95 | 58.33 | 1,746,286 |
| 08/09/26 | 58.97 | 59.41 | 57.55 | 57.67 | 2,538,923 |
| 04/09/26 | 58.502 | 59.255 | 58.455 | 59.01 | 1,580,946 |
|
|
||||
|
|
||||
|
|